CONTROLLED GLYCEMIC RESPONSE SWEETENED CEREAL PRODUCT
    2.
    发明申请
    CONTROLLED GLYCEMIC RESPONSE SWEETENED CEREAL PRODUCT 审中-公开
    控制的糖化反应甜味谷物产品

    公开(公告)号:WO2008030998A3

    公开(公告)日:2008-05-29

    申请号:PCT/US2007077824

    申请日:2007-09-07

    Abstract: The present invention provides a food product comprising: a formed reduced glycemic response cereal component; and a non-sticky reduced glyccmic response sweetener coating over the formed cereal component, the sweetener coating comprising: a first sticky layer comprising at least about 30% fructose (of the total sweetener coating); a second less sticky layer having a DE value of about 60 or less and comprising up to about 17% fructose and at least about 1% non-fructose carbohydrates (of the total sweetener coating); and third layer comprising crystalline fructose. The present invention also provides a process for forming the sweetener coating over the formed cereal component comprising the following steps: (a) providing a formed cereal component having thereon a first sticky layer comprising fructose; (b) forming over the first sticky layer a less sticky second layer comprising non- fructose carbohydrates and optionally fructose; and (c) applying crystalline fructose over the second layer.

    Abstract translation: 本发明提供了一种食品,其包含:形成的减少血糖反应谷物组分; 和在形成的谷物组分上的非粘性降低的糖基应答甜味剂包衣,所述甜味剂包衣包含:第一粘性层,其包含至少约30%的果糖(总甜味剂包衣); DE值为约60或更低且包含(总甜味剂包衣的)至多约17%果糖和至少约1%非果糖碳水化合物的第二较少粘性层; 和包含结晶果糖的第三层。 本发明还提供了一种在形成的谷物组分上形成甜味剂包衣的方法,包括以下步骤:(a)提供其上具有包含果糖的第一粘性层的成形谷物组分; (b)在第一粘性层上形成包含非果糖碳水化合物和任选的果糖的较少粘性的第二层; 和(c)在第二层上施用结晶果糖。

    TREATMENT OF INSULIN RESISTANCE ASSOCIATED WITH PROLONGED PHYSICAL INACTIVITY
    4.
    发明申请
    TREATMENT OF INSULIN RESISTANCE ASSOCIATED WITH PROLONGED PHYSICAL INACTIVITY 审中-公开
    与广泛的物理活动相关的胰岛素抵抗的治疗

    公开(公告)号:WO2014152606A3

    公开(公告)日:2015-02-05

    申请号:PCT/US2014027524

    申请日:2014-03-14

    Applicant: ABBOTT LAB

    Abstract: Insulin resistance biomarkers and related methods of using the biomarkers are provided. The biomarkers may be blood biomarkers and include C-peptide, Insulin-Like Growth Factor- Binding Protein 2 (IGFBP-2), and Leptin. Also provided is a method of reducing the effect of prolonged physical inactivity on insulin resistance in a subject who is experiencing prolonged physical inactivity, or who is expected to experience prolonged physical inactivity in the near future.

    Abstract translation: 提供了使用生物标志物的胰岛素抵抗生物标志物和相关方法。 生物标志物可以是血液生物标志物,包括C肽,胰岛素样生长因子结合蛋白2(IGFBP-2)和瘦蛋白。 还提供了一种减少长期身体不活动对经历长时间身体不活动的受试者或预期在不久的将来会经历长时间身体不活动的受试者的胰岛素抵抗的影响的方法。

Patent Agency Ranking